Kips Bay Liquidates As Its Bypass Graft Device Shows Poorly In Study
This article was originally published in The Gray Sheet
Executive Summary
The struggling Minnesota company made a last-ditch effort to complete the eMESH 1 trial of the eSVS Mesh device for coronary artery bypass graft surgery, but the firm, founded by device sector luminary Manny Villafana, has decided to give it up after the early results from the trial proved disappointing.